"Prognosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
| Descriptor ID |
D011379
|
| MeSH Number(s) |
E01.789
|
| Concept/Terms |
Prognostic Factors- Prognostic Factors
- Factor, Prognostic
- Factors, Prognostic
- Prognostic Factor
|
Below are MeSH descriptors whose meaning is more general than "Prognosis".
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Diagnosis [E01]
- Prognosis [E01.789]
Below are MeSH descriptors whose meaning is more specific than "Prognosis".
This graph shows the total number of publications written about "Prognosis" by people in this website by year, and whether "Prognosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 22 | 22 |
| 1997 | 0 | 27 | 27 |
| 1998 | 0 | 32 | 32 |
| 1999 | 0 | 30 | 30 |
| 2000 | 0 | 45 | 45 |
| 2001 | 0 | 36 | 36 |
| 2002 | 0 | 38 | 38 |
| 2003 | 0 | 51 | 51 |
| 2004 | 0 | 53 | 53 |
| 2005 | 0 | 60 | 60 |
| 2006 | 0 | 70 | 70 |
| 2007 | 0 | 87 | 87 |
| 2008 | 0 | 81 | 81 |
| 2009 | 0 | 103 | 103 |
| 2010 | 0 | 106 | 106 |
| 2011 | 0 | 124 | 124 |
| 2012 | 0 | 108 | 108 |
| 2013 | 2 | 142 | 144 |
| 2014 | 1 | 175 | 176 |
| 2015 | 0 | 179 | 179 |
| 2016 | 5 | 161 | 166 |
| 2017 | 3 | 200 | 203 |
| 2018 | 1 | 227 | 228 |
| 2019 | 1 | 235 | 236 |
| 2020 | 0 | 232 | 232 |
| 2021 | 1 | 148 | 149 |
| 2022 | 0 | 72 | 72 |
| 2023 | 0 | 94 | 94 |
| 2024 | 0 | 143 | 143 |
| 2025 | 0 | 126 | 126 |
| 2026 | 0 | 39 | 39 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prognosis" by people in Profiles.
-
Adding induction intrathecal cytarabine in newly diagnosed CNS2 B-acute lymphoblastic leukemia does not improve outcomes. Blood Adv. 2026 Jun 23; 10(12):4184-4192.
-
Prognostic Value of Inflammatory Biomarkers as Continuous Variables in Metastatic Renal Cell Carcinoma: Linearity Assessment, Proportional Hazards Assumption Testing, and Time-Varying Effects. Int J Urol. 2026 Jun; 33(6):e70536.
-
Clinical behavior and predictors of survival in major salivary gland secretory carcinoma. Oral Oncol. 2026 Aug; 179:108036.
-
Plasmablastic Lymphoma: 2026 Update on Diagnosis, Risk Stratification, and Management. Am J Hematol. 2026 Aug; 101(8):1997-2006.
-
Ethnic Differences in the Association Between SOD2 rs4880 and Hepatotoxicity in Pediatric Acute Lymphoblastic Leukemia: A Report From the REDIAL Consortium. Pediatr Blood Cancer. 2026 Jul; 73(7):e70387.
-
Early Liver Transplantation for Alcohol-Associated Hepatitis: A Systematic Review and Meta-Analysis. Clin Transplant. 2026 May; 40(5):e70566.
-
Long-Term Outcomes of Renal Transplant Allografts With De Novo DSA in the Setting of Stable Function. Clin Transplant. 2026 May; 40(5):e70576.
-
Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer. Anticancer Res. 2026 May; 46(5):2445-2453.
-
Burden of cardiovascular disease in Pakistan - insight from global burden of disease study 2019. BMC Cardiovasc Disord. 2026 Apr 22; 26(1).
-
Marrow-ablative chemotherapy and re-irradiation are associated with improved overall survival in patients with relapsed central nervous system nongerminomatous germ cell tumors. J Neurooncol. 2026 Apr 17; 177(3).